메뉴 건너뛰기
Medicina Clinica
Volumn 137, Issue 2, 2011, Pages 92-93
Emerging risk factors related to residual risk;Factores de riesgo emergentes relacionados con el riesgo residual
Author keywords

[No Author keywords available]
Indexed keywords

HUMAN; HYPERTENSION; LETTER; OBESITY; RISK FACTOR;
EID: 79958071008     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.025     Document Type: Letter
Times cited : (1)
References (10)
  • 1
    • 79958069148 scopus 로고    scopus 로고
    • Hierro y riesgo vascular residual dependiente del perfíl lipídico: una relación olvidada
    • del Castillo Rueda, A, Alvarez-Sala Walther L. Hierro y riesgo vascular residual dependiente del perfíl lipídico: una relación olvidada. Med Clin (Barc). 2010.
    • (2010) Med Clin (Barc)
    • Castillo Rueda, D.A.1    Alvarez-Sala Walther, L.2
  • 2
    • 77953870172 scopus 로고    scopus 로고
    • Riesgo vascular residual: Recomendaciones de la iniciativa española para la reducción del riesgo residual
    • J. Millán Núñez-Cortés, J. Pedro-Botet Montoya, and X. Pintó Sala Riesgo vascular residual: recomendaciones de la iniciativa española para la reducción del riesgo residual Med Clin (Barc). 135 2010 165 167
    • (2010) Med Clin (Barc). , vol.135 , pp. 165-167
    • Millán Núñez-Cortés, J.1    Pedro-Botet Montoya, J.2    Pintó Sala, X.3
  • 3
    • 56349154187 scopus 로고    scopus 로고
    • The Residual Risk Reduction Initiative: A call to action to reduce residual vascular risk in patients with dislypidemia
    • J.C. Fruchart, F. Sacks, M.P. Hermans, G. Assmann, W.V. Brown, and R. Ceska The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dislypidemia Am J Cardiol. 102 suppl 2008 1K 34K
    • (2008) Am J Cardiol. , vol.102 , Issue.SUPPL.
    • Fruchart, J.C.1    Sacks, F.2    Hermans, M.P.3    Assmann, G.4    Brown, W.V.5    Ceska, R.6
  • 4
    • 77955830245 scopus 로고    scopus 로고
    • Treatment of anemia in hearth failure: Potential risks and benefits of intravenous iron therapy in cardiovascular disease
    • Q. Jelani, and S.D. Katz Treatment of anemia in hearth failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease Cardiol Rev. 18 2010 240 250
    • (2010) Cardiol Rev. , vol.18 , pp. 240-250
    • Jelani, Q.1    Katz, S.D.2
  • 5
    • 69549107740 scopus 로고    scopus 로고
    • The association of biomarkers of iron status with peripheral arterial disease in US adults
    • A. Menke, J.M. Fernández-Real, P. Muntner, and E. Guallar The association of biomarkers of iron status with peripheral arterial disease in US adults BMC Cardiovasc Disord. 9 2009 34
    • (2009) BMC Cardiovasc Disord. , vol.9 , pp. 34
    • Menke, A.1    Fernández-Real, J.M.2    Muntner, P.3    Guallar, E.4
  • 6
    • 77949719651 scopus 로고    scopus 로고
    • Iron status is associated with carotid atherosclerotic plaques in middle-aged adults
    • N. Ahluwalia, A. Genoux, J. Ferrieres, B. Perret, M. Carayol, and L. Drouet Iron status is associated with carotid atherosclerotic plaques in middle-aged adults J Nutr. 140 2010 812 816
    • (2010) J Nutr. , vol.140 , pp. 812-816
    • Ahluwalia, N.1    Genoux, A.2    Ferrieres, J.3    Perret, B.4    Carayol, M.5    Drouet, L.6
  • 7
    • 79958034126 scopus 로고    scopus 로고
    • Ferritin levels, inflammatory biomarkers and mortality in peripheral arterial disease: As substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial
    • R.G. Depalma, V.W. Hayes, B.K. Chow, G. Shamayeva, P.E. May, and L.R. Zacharski Ferritin levels, inflammatory biomarkers and mortality in peripheral arterial disease: as substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial J Vasc Surg. 52 2010 536 537
    • (2010) J Vasc Surg. , vol.52 , pp. 536-537
    • Depalma, R.G.1    Hayes, V.W.2    Chow, B.K.3    Shamayeva, G.4    May, P.E.5    Zacharski, L.R.6
  • 8
    • 70149101527 scopus 로고    scopus 로고
    • Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2784 subjects
    • N. Friedrich, N. Milman, H. Volzke, A. Linneberg, and T. Jorgensen Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2784 subjects Br J Nutr. 102 2009 594 600
    • (2009) Br J Nutr. , vol.102 , pp. 594-600
    • Friedrich, N.1    Milman, N.2    Volzke, H.3    Linneberg, A.4    Jorgensen, T.5
  • 10
    • 74049103621 scopus 로고    scopus 로고
    • Serum ferritin is a major determinant op lipid phenotype in familial combined hyperlipidemia and familial hypertrygliceridemia
    • R. Mateo-Gallego, P. Calmarza, E. Jarauta, E. Burillo, A. Cenarro, and F. Civeira Serum ferritin is a major determinant op lipid phenotype in familial combined hyperlipidemia and familial hypertrygliceridemia Metabolism. 59 2010 154 158
    • (2010) Metabolism. , vol.59 , pp. 154-158
    • Mateo-Gallego, R.1    Calmarza, P.2    Jarauta, E.3    Burillo, E.4    Cenarro, A.5    Civeira, F.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.